Oncolytics Biotech Inc (TSX:ONC)
C$ 1.55 0.06 (4.03%) Market Cap: 119.13 Mil Enterprise Value: 95.39 Mil PE Ratio: 0 PB Ratio: 6.51 GF Score: 38/100

Oncolytics Biotech Inc. - Special Call Transcript

Apr 11, 2019 / 04:00PM GMT
Release Date Price: C$2.6 (+2.36%)
Tim McCarthy
LifeSci Advisors, LLC - Account Manager

Good afternoon. My name is Tim McCarthy with LifeSci Advisors. I'm the relationship manager working here with Oncolytics Biotech. So welcome to the Oncolytics KOL presentation. We're going to be covering biomarkers and oncolytic viruses. And we have a great line up with a great KOL, and we're going to have Dr. Matt Coffey kick everything off.

Matthew C. Coffey
Oncolytics Biotech Inc. - President, CEO & Director

Thanks, everyone. I'm Matt Coffey, and I know you're not here to listen to me speak today, so I'll be quick about it all. But what I'd like to do when I say your name, if you could just raise your hand so people in the crowd can see who you are.

Kirk Look, he is our Chief Financial Officer; Rita Laeufle -- Dr. Rita Laeufle is our Chief Medical Officer; Andrew de Guttadauro, Global Head of Business Development; Michael Moore, way in the back, Vice President Investor Relations; Grey Wilkinson, he's the gentleman responsible for a lot of work you'll see on the walls here. So if there are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot